Why the study?
Does tumor cell-derived ANGPTL2 drive metastasis and affect survival in lung cancer?
Population
Patients with lung cancer (surgical resection samples) and xenograft mouse models
Comparison
Attenuating ANGPTL2 expression in tumor cells /… vs Control / lower ANGPTL2 expression
Design
Preclinical
Authors
Loading...
Supports ANGPTL2 blockade to curb metastasis; leaves open clinical translation beyond xenograft models.
Does tumor cell-derived ANGPTL2 drive metastasis and affect survival in lung cancer?
Tumor cell-derived ANGPTL2 is a critical driver of metastasis, suggesting its blockade could be a therapeutic strategy in cancer.
Endo et al. (2012) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: